In the context of cancer, checkpoints play a dual role. On one hand, they prevent cells with damaged DNA from dividing, thereby acting as a safeguard against tumor formation. On the other hand, cancer cells often develop mechanisms to bypass these checkpoints, allowing them to proliferate uncontrollably. The loss of checkpoint function is a hallmark of many cancers, making them crucial targets for cancer therapies.
